Skip to main content

COVID-19 and impact on peer review

As a result of the significant disruption that is being caused by the COVID-19 pandemic we are very aware that many researchers will have difficulty in meeting the timelines associated with our peer review process during normal times.  Please do let us know if you need additional time. Our systems will continue to remind you of the original timelines but we intend to be highly flexible at this time.

COVID 19 Submission

Submit your research, review, or commentary related to Coronavirus to the Journal of Ovarian Research. The article will be fast-tracked for its rapid publication in the journal and may be eligible to have the APC waived.

Announcing the launch of In Review

In-Review

Journal of Ovarian Research, in partnership with Research Square, is now offering In Review. Authors choosing this free optional service will be able to:

  • Share their work with fellow researchers to read, comment on, and cite even before publication
  • Showcase their work to funders and others with a citable DOI while it is still under review
  • Track their manuscript - including seeing when reviewers are invited, and when reports are received 

New reviewer recruitment

New Content Item

The Journal of Ovarian Research invites you to join our team of reviewers in assessing manuscripts. For consideration, please send your CV to dana.dovey@biomedcentral.com.

Articles

Featured article

Thy-1 predicts poor prognosis and is associated with self-renewal in ovarian cancer

Ovarian cancer is the leading cause of gynecologic cancer death in the United States despite effective first-line systemic chemotherapy. Cancer stem cells (CSCs) retain the ability to self-renew and proliferate and may be a means of harboring disease that evades standard treatment strategies. We previously performed a high-throughput screen to assess differential protein expression in ovarian CSCs compared to non-CSCs and observed that Thy-1 was more highly expressed in CSCs. Our primary aim was to validate Thy-1 (CD90) as a cancer stem cell (CSC) marker in epithelial ovarian cancer (EOC), correlate with clinical outcomes, and assess as a potential therapeutic target.

Aims and scope

Journal of Ovarian Research is an open access, peer reviewed, online journal that aims to provide a forum for high-quality basic and clinical research on ovarian function, abnormalities, and cancer. The journal focuses on research that provides new insights into ovarian functions as well as prevention and treatment of diseases afflicting the organ.

Topical areas include, but are not restricted to:

  • Ovary development, hormone secretion and regulation
  • Follicle growth and ovulation
  • Infertility and Polycystic ovarian syndrome
  • Regulation of pituitary and other biological functions by ovarian hormones
  • Ovarian cancer, its prevention, diagnosis and treatment
  • Drug development and screening
  • Role of stem cells in ovary development and function

Journal of Ovarian Research is affiliated with the CROWN initiative, Core Outcomes in Women’s Health. CROWN is an international initiative, led by journal editors, to harmonise outcome reporting in women’s health research. We are coming together to address the widespread, unwarranted variation in reporting of outcomes. CROWN’s main aim is to encourage researchers to report core outcome sets for key conditions in women’s health.

Editors-in-Chief

Sham S Kakar, University of Louisville, USA

Benjamin K Tsang, University of Ottawa, Canada

Annual Journal Metrics